A recognized global leader in Robotic Focal Therapy, FocalTherics™ (NASDAQ: FOCL) develops, manufactures, and markets minimally invasive medical devices worldwide to treat various conditions using proprietary focused ultrasound technology. The Company’s flagship platform,Focal One®Robotic HIFU, combines advanced imaging, real-time treatment planning, robotic precision, and HIFU technology to deliver personalized focal therapy designed to optimize clinical outcomes while preserving quality of life. FocalTherics is committed to expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and global market development initiatives. For more information about FocalTherics, visitFocalTherics.com.
| Website | https://focalone.com |
| Employees | 265 (67 on RocketReach) |
| Address | 5321 Industrial Oaks Blvd Suite 110, Austin, Texas 78735, US |
| Phone | +1 512-832-7956 |
| Industry | Medical Equipment Manufacturing |
| Keywords | Hifu, Prostate Cancer Treatment, Robotic Surgery, High Intensity Focused Ultrasound, Focused Ultrasound, Surgical Robotics, Minimally Invasive Surgery, Precise Targeting, Therapeutic Ultrasound, Urological, Medical Technology, Surgical Technology, Advanced Surgery, Cancer Treatment, Medical Devices, Prostate Health, Healthcare Technology, Oncology |
| Competitors | Siemens Healthineers, GE HealthCare, Medtronic, Philips, Boston Scientific, Intuitive, Varian, Elekta, Accuray, Prostate Cancer Foundation +50 more (view full list) |
Looking for a particular Focal One employee's phone or email?
Ryan Rhodes is the CEO of Focal One.
67 people are employed at Focal One.
Focal One is based in Austin, Texas.